Edinburgh Research Explorer

Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2

Research output: Contribution to journalArticle

Standard

Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2. / UK10K Consortium; DDD study ; FitzPatrick, David.

In: Genetics in Medicine, 19.08.2017.

Research output: Contribution to journalArticle

Harvard

UK10K Consortium, DDD study & FitzPatrick, D 2017, 'Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2', Genetics in Medicine. https://doi.org/10.1038/gim.2016.211

APA

UK10K Consortium, DDD study, & FitzPatrick, D. (2017). Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2. Genetics in Medicine. https://doi.org/10.1038/gim.2016.211

Vancouver

UK10K Consortium, DDD study, FitzPatrick D. Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2. Genetics in Medicine. 2017 Aug 19. https://doi.org/10.1038/gim.2016.211

Author

UK10K Consortium ; DDD study ; FitzPatrick, David. / Clinical and Molecular Consequences of Disease-Associated De Novo Mutations in SATB2. In: Genetics in Medicine. 2017.